FI961169A - Kiteinen vedetön mykofenolaattimofetiili ja sen intravenoosivalmiste - Google Patents

Kiteinen vedetön mykofenolaattimofetiili ja sen intravenoosivalmiste Download PDF

Info

Publication number
FI961169A
FI961169A FI961169A FI961169A FI961169A FI 961169 A FI961169 A FI 961169A FI 961169 A FI961169 A FI 961169A FI 961169 A FI961169 A FI 961169A FI 961169 A FI961169 A FI 961169A
Authority
FI
Finland
Prior art keywords
mycophenolate mofetil
crystalline anhydrous
intravenous preparation
anhydrous mycophenolate
intravenous
Prior art date
Application number
FI961169A
Other languages
English (en)
Swedish (sv)
Other versions
FI119639B (fi
FI961169A0 (fi
Inventor
Roger Cherng Fu
De-Mei Leung
Jeffrey S Fleitman
Michele C Rizzolio
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of FI961169A0 publication Critical patent/FI961169A0/fi
Publication of FI961169A publication Critical patent/FI961169A/fi
Application granted granted Critical
Publication of FI119639B publication Critical patent/FI119639B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FI961169A 1993-09-15 1996-03-13 Menetelmä kiteisen vedettömän mykofenolaattimofetiilin ja sen intravenoosivalmisteen valmistamiseksi FI119639B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12184193A 1993-09-15 1993-09-15
US12184193 1993-09-15
PCT/US1994/010142 WO1995007902A1 (en) 1993-09-15 1994-09-12 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
US9410142 1994-09-12

Publications (3)

Publication Number Publication Date
FI961169A0 FI961169A0 (fi) 1996-03-13
FI961169A true FI961169A (fi) 1996-03-13
FI119639B FI119639B (fi) 2009-01-30

Family

ID=22399119

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961169A FI119639B (fi) 1993-09-15 1996-03-13 Menetelmä kiteisen vedettömän mykofenolaattimofetiilin ja sen intravenoosivalmisteen valmistamiseksi

Country Status (32)

Country Link
US (2) US5543408A (fi)
EP (1) EP0724581B1 (fi)
JP (1) JP3411038B2 (fi)
KR (1) KR100349772B1 (fi)
CN (1) CN1060770C (fi)
AT (1) ATE173475T1 (fi)
AU (1) AU677435B2 (fi)
BR (1) BR9407469A (fi)
CA (1) CA2171836C (fi)
CZ (1) CZ292423B6 (fi)
DE (1) DE69414720T2 (fi)
DK (1) DK0724581T3 (fi)
ES (1) ES2123831T3 (fi)
FI (1) FI119639B (fi)
HK (1) HK1012624A1 (fi)
HU (1) HU217300B (fi)
IL (1) IL110970A (fi)
LT (1) LT4052B (fi)
LV (1) LV11326B (fi)
MX (1) MXPA94007099A (fi)
NO (1) NO314727B1 (fi)
NZ (1) NZ273801A (fi)
PH (1) PH30685A (fi)
PL (1) PL178522B1 (fi)
RO (2) RO118075B1 (fi)
RU (1) RU2132849C1 (fi)
SG (1) SG55006A1 (fi)
SI (1) SI9420052B (fi)
TW (1) TW370527B (fi)
UA (1) UA49797C2 (fi)
WO (1) WO1995007902A1 (fi)
ZA (1) ZA947088B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512854D0 (en) * 1995-06-23 1995-08-23 Wellcome Found Novel formulation
IN188985B (fi) 1998-12-09 2002-11-30 Biocon Ltd
GB0301259D0 (en) 2003-01-20 2003-02-19 Novartis Ag Organic compounds
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
US20050187170A1 (en) * 2003-06-16 2005-08-25 Biocryst Pharmaceuticals, Inc. Enhancing the efficiency of RNA polymerase inhibitors by using inosine monophosphate dehydrogenase inhibitors
ES2308226T3 (es) * 2003-09-11 2008-12-01 Sandoz Ag Proceso para la produccion de micofenolato mofetil.
WO2005105768A2 (en) * 2004-04-26 2005-11-10 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg Process for preparation of mycophenolic acid and ester derivatives thereof
WO2005105769A2 (en) * 2004-04-27 2005-11-10 Teva Gyógyszergyár Zàrtköruen Muködo Rèszvènytàrsasàg - Mycophenolate mofetil impurity
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
CA2573781A1 (en) * 2004-07-20 2006-02-02 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Processes for preparation of crystalline mycophenolate sodium
CN100383520C (zh) * 2004-09-20 2008-04-23 复旦大学 一种测定人血浆中霉酚酸及其代谢物的方法
WO2006086500A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Compositions and methods for treating vascular, autoimmune and inflammatory diseases
WO2006086498A2 (en) * 2005-02-08 2006-08-17 Aspreva Pharmaceuticals Sa Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors
US20080280977A1 (en) * 2005-04-26 2008-11-13 Sandor Molnar Process for preparation of mycophenolate mofetil and other esters of mycophenolic acid
PL2032521T3 (pl) 2006-06-27 2010-05-31 Sandoz Ag Nowy sposób wytwarzania soli
CN101953807A (zh) * 2010-10-09 2011-01-26 山西普德药业有限公司 一种注射用吗替麦考酚酯冻干粉针剂及其制备方法
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
RS57497B1 (sr) 2013-03-14 2018-10-31 Alkermes Pharma Ireland Ltd Prolekovi fumarata i njihova upotreba u lečenju raznih bolesti
US9168246B2 (en) * 2013-06-27 2015-10-27 Veloxis Pharmaceutical A/S Regimen for suppressing organ rejection
EP3110793B1 (en) 2014-02-24 2019-08-21 Alkermes Pharma Ireland Limited Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases
US11918684B2 (en) 2017-03-13 2024-03-05 Liqmeds Worldwide Limited Pharmaceutical composition of oral suspension of immunosuppressive agents
CN117177749A (zh) 2021-03-03 2023-12-05 萨那生物科技公司 与心肌细胞疗法一起使用的免疫抑制疗法以及相关的方法和组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
US4478829A (en) * 1983-04-28 1984-10-23 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
US4753935A (en) 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions

Also Published As

Publication number Publication date
WO1995007902A1 (en) 1995-03-23
IL110970A0 (en) 1994-11-28
ATE173475T1 (de) 1998-12-15
LV11326A (lv) 1996-06-20
RO118427B1 (ro) 2003-05-30
RO118075B1 (ro) 2003-01-30
PL313480A1 (en) 1996-07-08
UA49797C2 (uk) 2002-10-15
BR9407469A (pt) 1996-11-12
EP0724581A1 (en) 1996-08-07
DK0724581T3 (da) 1999-08-02
SI9420052A (en) 1996-12-31
EP0724581B1 (en) 1998-11-18
DE69414720T2 (de) 1999-04-08
DE69414720D1 (de) 1998-12-24
IL110970A (en) 1999-01-26
NZ273801A (en) 1997-10-24
SG55006A1 (en) 1998-12-21
CA2171836A1 (en) 1995-03-23
SI9420052B (sl) 2004-02-29
HUT75119A (en) 1997-04-28
ES2123831T3 (es) 1999-01-16
US5545637A (en) 1996-08-13
CZ292423B6 (cs) 2003-09-17
CN1060770C (zh) 2001-01-17
NO314727B1 (no) 2003-05-12
FI119639B (fi) 2009-01-30
HK1012624A1 (en) 1999-08-06
FI961169A0 (fi) 1996-03-13
TW370527B (en) 1999-09-21
MXPA94007099A (es) 2004-01-23
CZ78896A3 (en) 1996-10-16
HU217300B (hu) 1999-12-28
CA2171836C (en) 2006-11-14
ZA947088B (en) 1996-03-14
LT4052B (en) 1996-10-25
LV11326B (en) 1996-10-20
NO961075D0 (no) 1996-03-15
US5543408A (en) 1996-08-06
HU9600652D0 (en) 1996-05-28
RU2132849C1 (ru) 1999-07-10
AU7723894A (en) 1995-04-03
JPH09502721A (ja) 1997-03-18
CN1131420A (zh) 1996-09-18
NO961075L (no) 1996-03-15
PH30685A (en) 1997-09-16
LT96028A (en) 1996-08-26
KR100349772B1 (ko) 2002-12-28
PL178522B1 (pl) 2000-05-31
AU677435B2 (en) 1997-04-24
JP3411038B2 (ja) 2003-05-26

Similar Documents

Publication Publication Date Title
FI961169A (fi) Kiteinen vedetön mykofenolaattimofetiili ja sen intravenoosivalmiste
BR9407910A (pt) Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
MY100359A (en) External pharmaceutical composition.
RU93004445A (ru) Новые 2-циано 3-гидроксиенамидные производные, способ их получения, их применение в качестве медикаментов, содержащие их фармацевтические композиции и новые полученные промежуточные продукты
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
GEP20032953B (en) Antitumor Agents
DE68929368D1 (de) Cephemderivate und Verfahren zu ihrer Herstellung
FR2412565A1 (fr) Nouveaux derives de type n-acyl-2', n-alkyl-2', di-n-acyl-4,2', di-n-alkyl-4,2', n-acyl-4 n-alkyl-2' et n-alkyl-4 n-acyl-2', desoxy-2 fortimicine b
NO301767B1 (no) Salt av clavulansyre
ATE35812T1 (de) Gamma-butyrolactonderivate, verfahren zur herstellung derselben und dieselben als aktive bestandteile enthaltende immunomodulierende zubereitungen.
WO1990003172A3 (en) Bile acids for treatment of viral infections
RU94021365A (ru) Производные метилпиперазиназепина, способ их получения, фармацевтическая композиция на их основе и использование производных в качестве фармацевтически активного вещества
GEP20033054B (en) 2,4,4-Trisubstituted-1,3-Dioxolane Antifungals
MX9600165A (es) 3-alcoxicarbonil-tiadiazinonas, proceso para su preparacion y composiciones farmaceuticas que las contienen.
ES2076517T3 (es) Ergolinas disustituidas en posiciones 2,13, su preparacion y utilizacion en medicamentos.

Legal Events

Date Code Title Description
MA Patent expired